Press Releases
Post a press release | Manage press releases
-
SpectronRx Begins Commercial-Scale Production of High-Purity Actinium-225, Strengthening Global Supply for Cancer Therapies
Press release from SpectronRx • Oct. 30, 2025 -
Greenstone Biosciences Advances AI-Driven Human Models for Drug Safety and Efficacy with NVIDIA
Press release from Greenstone Biosciences Inc • Oct. 28, 2025 -
Greenstone Biosciences and Illumina announce collaboration to advance precision drug discovery
Press release from Greenstone Biosciences Inc • Oct. 24, 2025 -
Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions
Press release from Assembled Intelligence • Oct. 23, 2025 -
Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity
Press release from Vial • Oct. 23, 2025 -
KFSHRC Achieves Breakthrough in Localizing Advanced Immunotherapies
Press release from King Faisal Specialist Hospital and Research Centre • Oct. 20, 2025 -
MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform
Press release from MMS • Oct. 16, 2025 -
Meta-Flux Raises $2M to Bridge Preclinical & Clinical Drug Development with AI
Press release from Meta-Flux • Oct. 13, 2025 -
Ellis Bio and UChicago Announce Breakthrough Ultra-Mild Bisulfite Sequencing Technology
Press release from Ellis Bio Inc • Oct. 10, 2025 -
Trinity Life Sciences Accelerates Future with Strategic Brand Transformation and AI-Enabled Solutions
Press release from Trinity Life Sciences • Oct. 8, 2025 -
XenoSTART and Minerva Imaging Expand Partnership to Deliver Integrated PDX-Radiopharmaceutical Drug Development Platform
Press release from The START Center for Cancer Research • Oct. 7, 2025 -
Thong Q. Le and Paul Sekhri Join Board of Directors at Deep Genomics
Press release from Deep Genomics • Oct. 7, 2025 -
PumasAI Unveils PumasAide, a Built-In AI Assistant to Accelerate Pharmacometric Research
Press release from PumasAI • Oct. 7, 2025 -
TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech
Press release from TrialAssure • Oct. 7, 2025 -
ROIS CDMO Acquires Pheonix Site
Press release from ROIS CDMO • Oct. 7, 2025 -
Boyd Biomedical Releases Study on Patient-Centric Medical Device Commercialization
Press release from Boyd Biomedical • Oct. 7, 2025 -
BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement
Press release from BrYet US Inc • Oct. 6, 2025 -
MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases
Press release from MMS • Oct. 2, 2025 -
Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein Cargo to the Brain
Press release from Mercury Bio • Oct. 1, 2025 -
MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers
Press release from MMS • Sept. 25, 2025
